Riskpilot← Back to searchSign inGet full accessK & K Pharma Oy
OYActiveY-tunnus 2450931-1Vadstenankatu 15Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20110 employees
Revenue 2024
EUR 2,2M
-3% vs 2023
EBITDA margin
22.6%
+13% vs 2023
Equity ratio
97.5%
Financial strength
Net profit 2024
EUR 399K
+9% vs 2023
| Revenue | EUR 2,2M | -3% |
| EBITDA | EUR 493K | +13% |
| Net profit | EUR 399K | +9% |
| Total assets | EUR 5,1M | +5% |
| Equity | EUR 5M | +5% |
| Employees | 0 | — |
Legal name
K & K Pharma Oy
Y-tunnus number
2450931-1
Legal form
Osakeyhtiö
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
28. joulukuuta 2011
Share capital
EUR 2 500
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on lääketieteellisten ja terveydenhoitoon liittyvien tuotteiden ja tarvikkeiden, kemikalio-, rohdos- ja luontaistuotteiden ja kosmetiikan vähittäis- ja tukkumyynti, tuonti, vienti ja valmistus ja lisäksi työvoiman sekä koneiden, laitteiden, kalusteiden, asuin- ja liikekiinteistöjen sekä huoneistojen vuokraus. Yhtiön toimialaan kuuluu myös lääke- ja apteekkialaan liittyvä konsultointi, tuotekehitys ja markkinointipalvelujen myynti sekä terveyden- ja sairaudenhoitopalvelujen tuottaminen. Yhtiö voi myös omistaa ja hallita arvopapereita, kiinteää ja irtainta omaisuutta, ostaa ja myydä arvopapereita, ostaa ja myydä asunto- ja kiinteistöyhtiön osakkeita sekä asuin- ja liikekiinteistöjä.
Address
Vadstenankatu 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 780 | 2 327 | 2 241 | 2 252 | 2 184 |
| Staff expenses | −0 | −9 | −9 | −25 | −25 |
| EBITDA | 565 | 656 | 527 | 438 | 493 |
| Depreciation & amort. | −68 | −44 | −33 | −60 | −40 |
| EBIT | 497 | 612 | 494 | 378 | 453 |
| Net financials | −19 | 57 | 78 | 66 | 32 |
| Profit before tax | 478 | 668 | 572 | 444 | 485 |
| Tax | 92 | 129 | 108 | 78 | 86 |
| Net profit | 387 | 539 | 464 | 366 | 399 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 265 | 4 652 | 4 715 | 4 903 | 5 139 |
| Equity | 3 671 | 4 232 | 4 545 | 4 762 | 5 011 |
| Long-term debt | 222 | — | — | 0 | 0 |
| Short-term debt | 373 | 420 | 170 | 141 | 128 |
| Total debt | 594 | 420 | 170 | 141 | 128 |
EBITDA margin
22.6%
This company
15.8%
Market median
+43% vs market
20202024
Equity ratio
97.5%
This company
38.2%
Market median
+155% vs market
20202024
Return on equity
8.0%
This company
18.4%
Market median
-57% vs market
20202024
Net profit margin
18.3%
This company
8.1%
Market median
+126% vs market
20202024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MM Deputy auditor | Deputy auditor | 2025 |
AR Deputy Member | Deputy Member | 2012 |
PK Chief Executive Officer | Chief Executive Officer | 2012 |
JF Audit | Audit | 2012 |
| Former (1) | ||
AG Deputy auditor | Deputy auditor | 2012 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of K & K Pharma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Minna Marianne Peräkorpi | Deputy auditor | 0 companies |
| Aarne Rainer Kumlin | Deputy Member | 0 companies |
| Petri Kullervo Kumlin | Chief Executive Officer | 0 companies |
| Anders Gabriel Björk | Deputy auditor | 0 companies |
| Johan-Erik Fant | Audit | 0 companies |
| Ida Alisa Aleksandra Kumlin | Board of Directors | 0 companies |